2022
DOI: 10.3389/fimmu.2022.1032294
|View full text |Cite
|
Sign up to set email alerts
|

Stress and cancer: The mechanisms of immune dysregulation and management

Abstract: Advances in the understanding of psychoneuroimmunology in the past decade have emphasized the notion that stress and cancer are interlinked closely. Durable chronic stress accelerated tumorigenesis and progression, which is unfavorable for clinical outcomes of cancer patients. Available evidence has provided unprecedented knowledge about the role and mechanisms of chronic stress in carcinogenesis, the most well-known one is dysfunction of the hypothalamus-pituitary-adrenal (HPA) axis and the sympathetic nervou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 178 publications
0
2
0
Order By: Relevance
“…Conventional anticancer therapies like chemotherapy, radiotherapy, surgery, and molecularly targeted therapies have all strived to correct this dysregulation of the stress‐immunity cycle by killing cancer cells and reduce tumor burden 8–10 . Unfortunately, over the last decades, these conventional anticancer therapies have achieved limited success in meaningfully prolonging the survival of patients.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Conventional anticancer therapies like chemotherapy, radiotherapy, surgery, and molecularly targeted therapies have all strived to correct this dysregulation of the stress‐immunity cycle by killing cancer cells and reduce tumor burden 8–10 . Unfortunately, over the last decades, these conventional anticancer therapies have achieved limited success in meaningfully prolonging the survival of patients.…”
Section: Introductionmentioning
confidence: 99%
“…7 Conventional anticancer therapies like chemotherapy, radiotherapy, surgery, and molecularly targeted therapies have all strived to correct this dysregulation of the stress-immunity cycle by killing cancer cells and reduce tumor burden. [8][9][10] Unfortunately, over the last decades, these conventional anticancer therapies have achieved limited success in meaningfully prolonging the survival of patients. This is due to both primary and acquired resistance of cancer cells against these therapies as well as their inability to properly reactivate our immune system against (residual) cancer cells.…”
mentioning
confidence: 99%